How Do Previous Solid Organ Transplant Recipients Fare After Primary Total Knee Arthroplasty?

Journal of Arthroplasty

Volumn 31, Issue 3, 2016, Pages 609-615.e1

  Klement, Mitchell R ^a   Penrose, Colin T ^a   Bala, Abiram ^a   Wellman, Samuel S ^a   Bolognesi, Michael P ^a   Seyler, Thorsten M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Complications; Primary knee arthroplasty; Solid organ transplant; Total knee replacement; Transplantation

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ELECTIVE SURGERY; ELIXHAUSER COMORBIDITY INDEX; FEMALE; FOLLOW UP; GENDER; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; ICD-9; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PATIENT HISTORY OF TRANSPLANTATION; PERIPROSTHETIC FRACTURE; POSTOPERATIVE COMPLICATION; PROSTHESIS INFECTION; TOTAL KNEE REPLACEMENT; VERY ELDERLY; ADVERSE EFFECTS; COMORBIDITY; FACTUAL DATABASE; KNEE; KNEE REPLACEMENT; MEDICARE; MIDDLE AGED; ODDS RATIO; PROCEDURES; RETROSPECTIVE STUDY; SURGERY; UNITED STATES;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; COMORBIDITY; DATABASES, FACTUAL; ELECTIVE SURGICAL PROCEDURES; FEMALE; HUMANS; KNEE; KNEE JOINT; MALE; MEDICARE; MIDDLE AGED; ODDS RATIO; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TRANSPLANT RECIPIENTS; UNITED STATES;

EID: 84958233759     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2015.10.007     Document Type: Article

References (35)

1. Annual Data Report of the US Organ Procurement and Transplantation Network (OPTN) and the Scientific Registry of Transplant Recipients (SRTR). Introduction. Am J Transplant 2013, 13(Suppl 1):8.
2. Ledford C.K., Watters T.S., Wellman S.S., et al. Risk versus reward: total joint arthroplasty outcomes after various solid organ transplantations. J Arthroplasty 2014, 29(8):1548.
3. Isono S.S., Woolson S.T., Schurman D.J. Total joint arthroplasty for steroid-induced osteonecrosis in cardiac transplant patients. Clinical Orthop Relat Res 1987, 217:201.
4. Ledford C.K., Watters T.S., Wellman S.S., et al. Outcomes of primary total joint arthroplasty after lung transplantation. J Arthroplasty 2014, 29(1):11.
5. Angermeier E.W., Demos H.A., Del Schutte H., et al. Complications of hip and knee joint replacement in solid-organ transplant patients. J Surg Orthop Adv 2013, 22(3):204.
6. Vergidis P., Lesnick T.G., Kremers W.K., et al. Prosthetic joint infection in solid organ transplant recipients: a retrospective case-control study. Transpl Infect Dis 2012, 14(4):380.
7. Papagelopoulos P.J., Hay J.E., Galanis E., et al. Infection around joint replacements in patients who have a renal or liver transplantation (79-A: 36-43, Jan. 1997), Tannenbaum et al. J Bone Joint Surg Am 1998, 80(4):607.
8. Maguire W.B., Muscio P., Dodd P.A. The results of joint replacement surgery in renal transplant patients. Aust N Z J Surg 1981, 51(6):534.
9. Papagelopoulos P.J., Hay J.E., Galanis E.C., et al. Total joint arthroplasty in orthotopic liver transplant recipients. J Arthroplasty 1996, 11(8):889.
10. Klatt B.A., Steele G.D., Fedorka C.J., et al. Solid organ transplant patients experience high rates of infection and other complications after total knee arthroplasty. J Arthroplasty 2013, 28(6):960.
11. Ferguson R.M., Henry M.L., Elkhammas E.A., et al. Twenty years of renal transplantation at Ohio State University: the results of five eras of immunosuppression. Am J Surg 2003, 186(3):306.
12. Durrbach A., Francois H., Beaudreuil S., et al. Advances in immunosuppression for renal transplantation. Nat Rev Nephrol 2010, 6(3):160.
13. McDonald-Hyman C., Turka L.A., Blazar B.R. Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation. Sci Transl Med 2015, 7(280):280rv2.
14. Wong J.M., Khan W.S., Chimutengwende-Gordon M., et al. Recent advances in designs, approaches and materials in total knee replacement: literature review and evidence today. J Perioper Pract 2011, 21(5):165.
15. Morris P.J. Transplantation-a medical miracle of the 20th century. N Engl J Med 2004, 351(26):2678.
16. Sayegh M.H., Carpenter C.B. Transplantation 50 years later-progress, challenges, and promises. N Engl J Med 2004, 351(26):2761.
17. Meier-Kriesche H.U., Baliga R., Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003, 75(8):1291.
18. Yu T.M., Lin C.L., Chang S.N., et al. Osteoporosis and fractures after solid organ transplantation: a nationwide population-based cohort study. Mayo Clinic Proc 2014, 89(7):888.
19. Bia M. Evaluation and management of bone disease and fractures post transplant. Transplant Rev (Orlando) 2008, 22(1):52.
20. Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 1996, 11(1):1.
21. Dolgos S., Hartmann A., Isaksen G.A., et al. Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation-a population based study. Clin Transpl 2010, 24(5):E145.
22. Shaikh K.A., Helbig G.M., Shapiro S.A., et al. Spinal surgery following organ transplantation. J Neurosurg Spine 2011, 14(6):779.
23. Gallagher K.A., Ravin R.A., Schweitzer E., et al. Outcomes and timing of aortic surgery in renal transplant patients. Ann Vasc Surg 2011, 25(4):448.
24. Wei C.K., Chang C.M., Lee C.H., et al. Acute appendicitis in organ transplantation patients: a report of two cases and a literature review. Ann Transplant 2014, 19:248.
25. Koonce S.L., Giles B., McLaughlin S.A., et al. Breast reconstruction after solid organ transplant. Ann Plast Surg 2015, 75:343-347.
26. Elixhauser A., Steiner C., Harris D.R., et al. Comorbidity measures for use with administrative data. Med Care 1998, 36(1):8.
27. Chu Y.T., Ng Y.Y., Wu S.C. Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality. BMC Health Serv Res 2010, 10:140.
28. Shin J.H., Worni M., Castleberry A.W., et al. The application of comorbidity indices to predict early postoperative outcomes after laparoscopic Roux-en-Y gastric bypass: a nationwide comparative analysis of over 70,000 cases. Obes Surg 2013, 23(5):638.
29. Saez-Gimenez B., Berastegui C., Loor K., et al. Deep vein thrombosis and pulmonary embolism after solid organ transplantation: an unresolved problem. Transplant Rev (Orlando) 2015, 29(2):85.
30. Anderson F.A., Huang W., Friedman R.J., et al. Prevention of venous thromboembolism after hip or knee arthroplasty: findings from a 2008 survey of US orthopedic surgeons. J Arthroplasty 2012, 27(5):659.
31. Issa N., Kukla A., Ibrahim H.N. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. Am J Nephrol 2013, 37(6):602.
32. Naesens M., Kuypers D.R., Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009, 4(2):481.
33. Cavanaugh P.K., Chen A.F., Rasouli M.R., et al. Total joint arthroplasty in transplant recipients: in-hospital adverse outcomes. J Arthroplasty 2015, 30(5):840.
34. Leung K.H., Chiu K.Y., Yan C.H., et al. Review article: venous thromboembolism after total joint replacement. J Orthop Surg (Hong Kong) 2013, 21(3):351.
35. Zhu Y., Zhang F., Chen W., et al. Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. J Hospital Infection 2015, 89(2):82.